Agios Pharmaceuticals (AGIO) Reports Q4 Loss of $108M, Surpasses Estimates

Agios Pharmaceuticals Inc. (AGIO) reported a fourth-quarter loss of $108 million, or $1.85 per share, on Thursday. Revenue for the quarter was $20 million, exceeding the $10.3 million average estimate from six analysts surveyed by Zacks Investment Research. For the year, the company recorded a loss of $412.8 million, or $7.12 per share, with revenue of $54 million. The stock rose 1.9% since the start of 2026, while it has declined 15% over the past 12 months.